Topics in Anti-Cancer Research

Volume 3

by

Atta-ur-Rahman / Khurshid Zaman

DOI: 10.2174/97816080590891140301
eISBN: 978-1-60805-908-9, 2014
ISBN: 978-1-60805-909-6
ISSN: 2468-5860 (Print)
ISSN: 2213-3585 (Online)



Indexed in: Book Citation Index, Science (BKCI-S), Chemical Abstracts, BIOSIS Previews, EBSCO, Ulrich's Periodicals Directory.

This is the third volume of the Patent eBook Series entitled Topics in Anti-Cancer Research. This eBook comprises updated reviews on t...[view complete introduction]
US $
Buy Personal eBook
129
Order Library eBook
516
Order Printed Copy
*209
Order PDF + Printed Copy (Special Offer)
*273

*(Excluding Mailing and Handling)

🔒Secure Checkout Personal information is secured with SSL technology
Download Flyer

Proteome-Based Anti-Tumor Cell Therapy

- Pp. 484-529 (46)

Andrey S. Bryukhovetskiy, Valeriy E. Shevchenko, Sergey V. Kovalev, Vladimir G. Polyakov, Igor S. Bryukhovetskiy and Maria V. Zhukova

Abstract

The chapter is dedicated to the issues of clinical oncoproteomics, its role and place in contemporary medicine in general, and in oncology in particular. We attempted to systemize the views of different researchers and detect information and significance of the evidence of clinical oncoproteomics for the development of novel methods of diagnostics and cancer therapy using cell, genome and post-genome technologies. The chapter summarizes contemporary ideas of tumor carcinogenesis centrally laying emphasis on the theoretical, methodological and technic the aspects of the novel medical approach of personalized proteome-based cell therapy of neoplasms. Experience of mapping, proteome and transcriptome profiling of postnatal regional progenitors and cancer stem cells in different cancer cases, methods of bioinformatical processing and mathematical modeling of the results have been elucidated. The basic mathematical tool kit to detect targets for the regulation of proliferative and reproductive functions of cancer stem cell in the tumor and the way to obtain target individually tailored anti-cancer proteome-modified cell preparations have been highlighted. Further, the mechanisms, limitations and prospects of application of these biotechnologies based on clinical oncoproteomics in the target therapy of cancer and recent patents have also been discussed.

Purchase Chapter  Book Details

Advertisement


Webmaster Contact: info@benthamscience.net Copyright © 2019 Bentham Science